755 related articles for article (PubMed ID: 30985608)
21. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over intravenous immunoglobulin.
Buzzigoli SB; Genovesi M; Lambelet P; Logi C; Raffaelli S; Cattano D
Anaesth Intensive Care; 2010 Mar; 38(2):387-9. PubMed ID: 20369779
[TBL] [Abstract][Full Text] [Related]
22. Outcome of axonal and demyelinating forms of Guillain-Barré syndrome in children.
Tekgul H; Serdaroglu G; Tutuncuoglu S
Pediatr Neurol; 2003 Apr; 28(4):295-9. PubMed ID: 12849884
[TBL] [Abstract][Full Text] [Related]
23. Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome.
Singhi SC; Jayshree M; Singhi P; Banerjee S; Prabhakar S
Ann Trop Paediatr; 1999 Jun; 19(2):167-74. PubMed ID: 10690257
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
[TBL] [Abstract][Full Text] [Related]
26. Guillain-Barré syndrome.
Hughes RA; Cornblath DR
Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Hadden RD; Cornblath DR; Hughes RA; Zielasek J; Hartung HP; Toyka KV; Swan AV
Ann Neurol; 1998 Nov; 44(5):780-8. PubMed ID: 9818934
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome: subtypes and predictors of outcome from India.
Kalita J; Misra UK; Goyal G; Das M
J Peripher Nerv Syst; 2014 Mar; 19(1):36-43. PubMed ID: 24456386
[TBL] [Abstract][Full Text] [Related]
29. Childhood Guillain-Barré syndrome subtypes in northern India.
Sankhyan N; Sharma S; Konanki R; Gulati S
J Clin Neurosci; 2014 Mar; 21(3):427-30. PubMed ID: 24128771
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for the sequelae and severity of Guillain-Barré syndrome in children.
Estrade S; Guiomard C; Fabry V; Baudou E; Cances C; Chaix Y; Cintas P; Meyer P; Cheuret E
Muscle Nerve; 2019 Dec; 60(6):716-723. PubMed ID: 31531862
[TBL] [Abstract][Full Text] [Related]
31. Guillain-Barre syndrome in North Indian children: Clinical and serial electrophysiological features.
Yadav S; Jain P; Sharma S; Kumar V; Aneja S
Neurol India; 2019; 67(3):724-727. PubMed ID: 31347543
[TBL] [Abstract][Full Text] [Related]
32. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome.
Kalita J; Misra UK; Das M
J Neurol Neurosurg Psychiatry; 2008 Mar; 79(3):289-93. PubMed ID: 17615164
[TBL] [Abstract][Full Text] [Related]
33. [Guillain-Barré syndrome with preserved reflexes].
Zouiri G; Abilkassem R; Zerhouni A; Dini N; Agadr A
Arch Pediatr; 2016 May; 23(5):501-3. PubMed ID: 27021810
[TBL] [Abstract][Full Text] [Related]
34. Guillain-Barré syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature.
Ralapanawa U; Kumarihamy P; Jayalath T; Udupihille J
J Med Case Rep; 2019 Jul; 13(1):221. PubMed ID: 31324211
[TBL] [Abstract][Full Text] [Related]
35. Acute motor-sensory axonal Guillain-Barré syndrome with unilateral facial nerve paralysis after rotavirus gastroenteritis in a 2-year-old boy.
Kamihiro N; Higashigawa M; Yamamoto T; Yoshino A; Sakata K; Nashida Y; Maji T; Fujiwara T; Inoue M
J Infect Chemother; 2012 Feb; 18(1):119-23. PubMed ID: 21915637
[TBL] [Abstract][Full Text] [Related]
36. A rare mimic of acute stroke: rapidly progressing Miller-Fisher Syndrome to acute motor and sensory axonal neuropathy variant of Guillain-Barre Syndrome.
de Castillo LLC; Diestro JDB; Ignacio KHD; Pasco PMD
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936342
[TBL] [Abstract][Full Text] [Related]
37. Intravenous immunoglobulin for Guillain-Barré syndrome: how effective?
Tasdemir HA; Dilber C; Kanber Y; Uysal S
J Child Neurol; 2006 Nov; 21(11):972-4. PubMed ID: 17092465
[TBL] [Abstract][Full Text] [Related]
38. Acute axonal neuropathy subtype of Guillain Barré syndrome in a French pediatric series: Adequate follow-up may require repetitive electrophysiological studies.
Chareyre J; Hully M; Simonnet H; Musset L; Barnerias C; Kossorotoff M; Quijano-Roy S; Desguerre I; Gitiaux C
Eur J Paediatr Neurol; 2017 Nov; 21(6):891-897. PubMed ID: 28754297
[TBL] [Abstract][Full Text] [Related]
39. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
[TBL] [Abstract][Full Text] [Related]
40. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication.
Chakraborty U; Hati A; Chandra A
Diabetes Metab Syndr; 2021; 15(6):102326. PubMed ID: 34731822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
